Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sylvie Bonvalot"'
Autor:
Lounes Djerroudi, Julien Masliah-Planchon, Hervé J. Brisse, Sophie El Zein, Sylvie Helfre, Dimitri Tzanis, Nadim Hamzaoui, Clément Bonnet, Valérie Laurence, Sylvie Bonvalot, Sarah Watson
Publikováno v:
JCO Precision Oncology.
Autor:
Jessica M. Frakes, Yun Hu, Juliette Thariat, Tanguy Y. Seiwert, Jiaxin Niu, Maria Angelica Cortez, Ping Zhang, K. Jameson, Sylvie Bonvalot, Sébastien Paris, Colette J. Shen, James W. Welsh, Zsuzsanna Papai, Jimmy J. Caudell, Jared Weiss, Hampartsoum B. Barsoumian, P. Said
Publikováno v:
Journal of Clinical Oncology. 39:2591-2591
2591 Background: Despite recent advances, resistance to immune checkpoint inhibitors (ICI), observed in over 80% of treated patients, is currently the main challenge in immuno-oncology. Intense efforts are being made to identify combination therapies
Autor:
Jean Emmanuel Kurtz, Jean-Yves Blay, Alexandra Meurgey, Daniel Orbach, Olivier Collard, Sophie Piperno-Neumann, Pascaline Boudou-Rouquette, Antoine Italiano, C. Guillemet, Christine Chevreau, Axel Le Cesne, Nicolas Penel, Marie-Cécile Le Deley, Julien Thery, Sylvie Bonvalot, André-Michel Bimbai, Sébastien Salas, Thomas Ryckewaert, Olivier Mir, François Le Loarer
Publikováno v:
Journal of Clinical Oncology. 39:11510-11510
11510 Background: DF rare locally aggressive fibroblastic non-metastasizing tumor, with an unpredictable course. Its management remains challenging, there is a current shift in standard of care from large surgical resection (SR) to active surveillanc
Autor:
S. Carrere, Piotr Rutkowski, Sunyach Marie, B. Tiangco, Rubi Khaw Li, Juliette Thariat, Cécile Le Péchoux, Zsuzsanna Papai, P. Agoston, Victor Moreno, Anne Ducassou, Marco Rastrelli, Sylvie Bonvalot, Act.In.Sarc. investigators, Angela Hong, A. Mervoyer
Publikováno v:
Journal of Clinical Oncology. 39:11544-11544
11544 Background: NBTXR3, a novel radioenhancer activated by radiotherapy (RT) demonstrated superior efficacy, as preoperative treatment, in patients with locally advanced soft tissue sarcoma (LA STS), compared to RT alone. Primary endpoint of pCR ra
Autor:
Angela Botticella, Dario Callegaro, Cécile Le Péchoux, Axel Le Cesne, Alessandro Gronchi, Antonin Levy, Sylvie Bonvalot
Publikováno v:
Journal of Clinical Oncology. 36:2357-2358
Autor:
Saskia Litière, Piotr Rutkowski, Sandrine Marreaud, Marco Fiore, Hans Gelderblom, Pierre Meeus, Carol Jane Swallow, Claudia Sangalli, Charles Honoré, Dirk C. Strauss, Frits van Coevorden, Alessandro Gronchi, Peter Chung, Sylvie Bonvalot, Eberhard Stoeckle, Marco Rastrelli, Stephan Stoldt, Rick L. Haas, Cécile Le Péchoux, Chandrajit P. Raut
Publikováno v:
Journal of Clinical Oncology. 37:11001-11001
11001 Background: The predominant pattern of failure of retroperitoneal sarcoma (RPS), frequently associated with subsequent death, is locoregional recurrence. Unlike in limbs, the efficacy of radiotherapy (RT) combined with surgery is not establishe
Autor:
Mikael Ropars, Jerome Guiramand, Loic-Romée Le Nail, Sylvie Bonvalot, Philippe Anract, Jean-Yves Blay, Antoine Italiano, Francois Sirveaux, Charles Honoré, Sébastien Carrère, François Gouin, Gauthier Decanter, Oren Marco, Antonio DiMarco, Nicolas Penel, Gwenael Ferron, Emmanuelle Bompas, Eberhard Stoeckle, Richard Rochwerger, Axel Le Cesne
Publikováno v:
Journal of Clinical Oncology. 37:11056-11056
11056 Background: We previously reported that secondary resection (2Surg) improved local relapse free (LRFS) but not overall survival (OS) in a retrospective series of pts with localized STS after unplanned 1st excision. Here we investigated the impa
Autor:
Axel Le Cesne, Philippe Rochaix, C. Llacer-Moscardo, Péter Ágoston, N. Fernando, Isabelle Birtwisle-Peyrottes, Hervé Brisse, Colette J. Shen, Zoltán Sápi, Juliette Thariat, Tanguy Y. Seiwert, Marie-Christine Chateaux, Sébastien Carrère, Sunyach Marie, Marick Laé, Zsuzsanna Papai, Bradford Perez, Sylvie Bonvalot, Anne Ducassou
Publikováno v:
Journal of Clinical Oncology. 37:e14609-e14609
e14609 Background: Radiotherapy (RT) can prime an anti-tumor immune response. Unfortunately, this response rarely generates total tumor destruction and abscopal effect. When activated by RT, intratumorally (IT) administered hafnium oxide nanoparticle
Autor:
Carine Bellera, Jean-Yves Blay, Sophie Piperno-Neumann, Emmanuelle Bompas, Eberhard Stoeckle, Sylvie Bonvalot, Charles Honoré, François Bertucci, Antoine Italiano, Christine Chevreau, Florence Duffaud, Axel Le Cesne
Publikováno v:
Journal of Clinical Oncology. 37:TPS11078-TPS11078
TPS11078 Background: We have recently identified a gene expression signature so called “CINSARC” which is related with chromosomal instability and highly predictive of metastasis-free and overall survival in soft-tissue sarcoma (STS) patients. Th
Autor:
Christophe Le Tourneau, Sylvie Bonvalot, Tanguy Y. Seiwert, Valentin Calugaru, Corey C. Foster
Publikováno v:
Journal of Clinical Oncology. 37:TPS23-TPS23
TPS23 Background: Despite proven efficacy, a limited number of patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) or metastatic non-small cell lung cancer (NSCLC) benefit from anti-PD-1 treatment. Indeed, most pts